The Effect of Pharmacist Intervention on the Use of Zostavax in a Community Pharmacy Setting

Completed · Not applicable

Conditions studied: Herpes Zoster

In brief

The purpose of this study is to determine whether pharmacist-driven patient interventions can have an effect on the number of herpes zoster (Zostavax) vaccinations given in a community pharmacy setting.

Key facts

Study ID

NCT00689013

Run by

University of Tennessee

People needed

205

Starts

2008-02-01

Expected to finish

2008-03-01

Last updated by the study team

2009-04-23

Who can join

Age: 60 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• men and women aged 60 or older without contraindications for the herpes zoster vaccination
• patients who have already experienced one or more episodes of herpes zoster infection were considered for vaccine receipt and study inclusion secondary to CDC ACIP recommendations

You may not qualify if…

• Patients aged < 60 years
• Anyone who has previously received the herpes zoster vaccine
• Anyone with an allergy to neomycin, gelatin or any other component of the vaccine
• Anyone receiving a live vaccine within 4 weeks
• Anyone with a compromised or weakened immune systems such as those receiving radiation, corticosteroids, or those with HIV/AIDS, cancer in the lymph, bone or blood systems
• Pregnant women or those in close contact with a pregnant woman

Where it is running

• Wilson Pharmacy — Johnson City, Tennessee, United States
• Marcrom's Pharmacy — Manchester, Tennessee, United States
• Reeves-Sain Drug Store — Murfreesboro, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.